Heart disease remains a primary cause of illness and mortality around the world. While ...

Outperformed Approved Pan-HDAC Inhibitor Givinostat in Improving Muscle Function and Correcting Drivers of DMD Cardiomyopathy New Data Confirm TN-301’s Differentiated Mechanism and Opportunities to ...

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking ...

For a heart just damaged by a blocked artery, timing matters. So does access. That is what makes a new experimental treatment ...

A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of ...

More than 300,000 people suffer a heart attack in Germany every year. The heart muscle is then no longer supplied with sufficient blood and oxygen, and part of the tissue dies and scars. Unlike the ...

NOVEL heart failure (HF) research has identified a surprising protective signal produced directly by heart muscle cells that may help slow the development of cardiac fibrosis, a key driver of ...

Precision BioSciences Inc. (NASDAQ:DTIL) presented new preclinical findings for its PBGENE-DMD gene therapy at the Muscular ...

Human heart cells and tissues grown in the laboratory from stem cells promise to accelerate the development of drugs and treatments for heart disease, but they currently take weeks or months to grow.

A new study suggests that widely used GLP-1 weight-loss drugs may do more than improve metabolic health: they could also protect the heart after a heart attack. Doctors can often reopen the blocked ...

Popular weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may do more than help people shed pounds. New research suggests these GLP-1 medications could also help protect the heart after a heart ...

Drugs originally developed to help people lose weight and control blood sugar may also help the heart recover after a heart attack, according to new research led by scientists at the University of ...